No abstract available
Keywords:
CA-MRSA; Infection control; MSSA; PVL; Panton–Valentine leukocidin; Staphylococcus aureus.
MeSH terms
-
Animals
-
Anti-Bacterial Agents / pharmacology
-
Bacterial Toxins / metabolism*
-
Chlorhexidine / pharmacology
-
Community-Acquired Infections / drug therapy
-
Community-Acquired Infections / microbiology
-
Community-Acquired Infections / prevention & control
-
Exotoxins / metabolism*
-
Humans
-
Leukocidins / metabolism*
-
Methicillin-Resistant Staphylococcus aureus / drug effects
-
Mupirocin / pharmacology
-
Pets
-
Pneumonia, Bacterial / drug therapy
-
Pneumonia, Bacterial / microbiology
-
Prevalence
-
Staphylococcal Infections / drug therapy*
-
Staphylococcal Infections / epidemiology
-
Staphylococcal Infections / etiology*
-
Staphylococcal Infections / prevention & control
-
Staphylococcal Skin Infections / drug therapy
-
Staphylococcal Skin Infections / microbiology
-
Staphylococcus aureus / drug effects*
-
Staphylococcus aureus / metabolism*
-
Staphylococcus aureus / pathogenicity
-
Zoonoses / microbiology
Substances
-
Anti-Bacterial Agents
-
Bacterial Toxins
-
Exotoxins
-
Leukocidins
-
Panton-Valentine leukocidin
-
Mupirocin
-
Chlorhexidine